Automated External Defibrillator Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Automated External Defibrillator Market Trends and Insights

Rising Incidence of Sudden Cardiac Arrest (SCA)

Out-of-hospital SCA reached 350,000 U.S. events annually, and survival drops roughly 10% with every minute’s delay to defibrillation.^{[1]Samya Madhukar and Gina Peattie, “Latest Statistics,” Sudden Cardiac Arrest Foundation, sca-aware.org} New American Heart Association 2025 guidelines shorten recommended response intervals and broaden pediatric protocols, prompting higher device densities in schools and sports venues.^{[2]American Heart Association, “2025 American Heart Association Guidelines for CPR and ECC,” American Heart Association, cpr.heart.org} Municipal planners now map four-minute walk radii for AED placement, while during the CPR Awareness Week, India's Ministry of Health engaged over 747,000 citizens, providing physical training to more than 606,374 participants nationwide.^{[3]Press Information Bureau Staff, “Pan-India CPR Awareness Week Organized by Ministry of Health and Family Welfare to Strengthen Community Response Capacity,” Press Information Bureau, pib.gov.in} Aging populations intensify baseline risk in Japan and Europe, but middle-income Asia-Pacific nations record the steepest absolute growth because lifestyle diseases are outpacing emergency-response build-outs.

Government-Funded Public-Access Defibrillation (PAD) Programs

China installed more than 64,000 public-access units in 2024, and Beijing committed to 2,000 networked cabinets with GPS telemetry. The United Kingdom set aside GBP 1 million (USD 1.27 million) in 2025 to place 2,000 devices in underserved areas. U.S. jurisdictions such as New York City and New Hampshire translate policy into bulk-buy contracts that quote Philips HeartStart OnSite at USD 898.79 and ZOLL AED Plus at USD 1,070. European decrees in France, Germany and Italy similarly mandate defibrillators in public buildings, creating predictable replacement cycles.

Technological Shift to Biphasic & Impedance-Compensated Waveforms

Biphasic shocks deliver higher first-shock success and less myocardial injury than legacy monophasic energy, an advantage embedded in FDA 510(k) clearances. ZOLL’s rectilinear biphasic waveform, validated in trials of 11,500 patients, underpins the AED 3 and AED Plus lines. Stryker’s LIFEPAK CR2 analyses rhythm during compressions, while Philips and Nihon Kohden add real-time impedance adjustment. Regulators harmonize dossiers under EU MDR, accelerating global rollouts and driving a replacement wave away from monophasic stock.

Integration into Smart-City IoT Emergency Networks

Daily self-test telemetry from Nihon Kohden’s Cardiolife AED-3100 flows via Bluetooth to cloud dashboards, alerting managers to expiring pads. ZOLL’s PlusTrac software links Wi-Fi equipped AED 3 units to dispatch centers, and Beijing pilots route the nearest trained bystander through WeChat when a 911-equivalent call falls within 300 meters of a registered cabinet. South Korea’s Emergency Medical Service Act encourages similar telemetry ties to its national 119 system. These integrations cut median time-to-shock by two to three minutes in early studies, justifying higher upfront device costs.

High Acquisition & Maintenance Cost for Small Institutions

A basic AED sells for USD 849-1,795, but five-year ownership doubles after pad, battery, cabinet and training expenses. Small nonprofits often depend on donated, non-connected devices, leaving one in five units unusable when needed. Grants exist yet administrative burdens deter the smallest clinics and volunteer fire departments, perpetuating geographic inequity.

Limited Reimbursement & Liability Concerns in Emerging Markets

National insurance schemes in India and Indonesia do not reimburse AED purchases, and Good Samaritan protections remain untested in courts, suppressing bystander willingness to intervene. China’s installations vary by province, and insurance carriers in many emerging markets exclude AED-related claims, forcing institutions to self-insure.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Product Type: Semi-Automatic Dominance Yields to Full-Auto Simplicity

Semi-automatic units controlled 58.24% automated external defibrillator market share in 2025, reflecting decades of training that tells rescuers to press a button only after confirming safety. Fully-automatic devices will compound at 9.78% through 2031 as public venues prefer hardware that fires without hesitation. ZOLL’s AED 3 and Stryker’s LIFEPAK CR2 come in both modes, letting buyers match user profiles. Airports and stadiums lean toward full-auto for untrained crowds, whereas hospitals still favor semi-auto for clinical oversight. Pricing parity—it often costs less than USD 100 to switch modes—removes cost as a barrier, leaving policies and confidence to steer adoption. 

Fully-automatic gains feed the automated external defibrillator market by shortening pause time, which studies link to higher return-of-spontaneous-circulation rates. Regulatory frameworks in Japan and South Korea allow both modes, though their training curricula still echo semi-auto norms, slowing transition. As more public-access networks go live, familiarity with hands-free operation should accelerate replacement demand for semi-auto stock, nudging the automated external defibrillator industry toward simplicity.

By Technology: Biphasic Waveforms Cement Preference

Biphasic platforms captured 91.11% share of automated external defibrillator market size in 2025 and will rise 9.45% annually. FDA registrants now use biphasic comparators for substantial equivalence, effectively making monophasic filings obsolete. ZOLL’s rectilinear waveform adjusts energy to patient impedance, while Stryker’s cprINSIGHT analyzes rhythm without stopping compressions, removing one to two minutes of idle time per case. 

Monophasic devices linger in older hospital inventories and low-income markets, but Chinese exporters are also adopting biphasic designs, cutting price gaps and speeding global phase-out. These advances align with studies showing higher first-shock efficacy and lower tissue damage, guaranteeing that future automated external defibrillator market replacements gravitate to biphasic hardware.

By Modality: Public-Access Surge Challenges Professional-Use Incumbency

Professional-use models owned 61.73% of revenue in 2025 because hospitals and EMS fleets value manual overrides and ECG integration. Yet public-access units are set to outgrow them at 10.25% CAGR as municipalities, schools and corporations follow updated building codes. China’s Red Cross placed 64,000 devices in 2024, and the U.K. funded another 2,000 for underserved areas, adding momentum. 

Public-access buyers seek three-step voice-prompt simplicity, multilingual support and Wi-Fi self-tests, all while keeping prices between USD 849 and USD 1,795. EMS agencies will still buy rugged units with IP55 housing and longer-life batteries, but the volume story for the automated external defibrillator market clearly tilts toward public venues.

By End User: Public Access Locations Outpace Hospital Incumbents

Hospitals and clinics held 58.34% share in 2025, anchored by mandatory crash-cart stocking and data-system integration. Public-access sites, however, are expanding fastest at 10.64% CAGR, driven by building mandates and liability mitigation at sports arenas, transit hubs and office towers. New York City’s Local Law 20 and France’s Decree 2018-1186 crystallize these obligations. 

Emergency medical services equip transport-grade models that survive temperature extremes, while home-care uptake remains low because consumer units still exceed USD 1,000. Venture-backed platforms like Avive aim to lower thresholds with connected home devices and subscription monitoring, foreshadowing another wave of automated external defibrillator market growth once payers and regulators catch up.

Geography Analysis

North America contributed 44.22% of 2025 revenue thanks to mature public-access legislation in all 50 U.S. states and federal grants under the Rural Access to Emergency Devices Act. New American Heart Association guidelines published in 2025 adjust device specs for schools and childcare centers. Canada and Mexico trail the U.S. in per-capita deployment but offer catch-up opportunity as provinces and private employers fund new placements. 

Asia-Pacific is on track for the fastest 9.34% regional CAGR through 2031. China’s Red Cross installed 64,000 devices in 2024 and Beijing ordered 2,000 smart cabinets with live GPS feeds. Japan’s Fire and Disaster Management Agency continues to push devices into public facilities, and South Korea’s EMS Act requires units in schools and large commercial buildings. India’s CPR Awareness Week trains 606,374, yet federal AED mandates and liability clarity remain pending, limiting immediate conversion. 

Europe balances moderate growth with stringent environmental rules. The United Kingdom has earmarked GBP 1 million for community placements, and France, Germany and Italy enforce location-specific mandates. The EU Battery and WEEE Directives raise compliance costs but also motivate upgrades to longer-life batteries and pad recycling programs. Middle East-Africa and South America remain nascent, although GCC nations and Brazil’s metro health secretariats are piloting public-access programs that could scale on positive survival data.

Regulatory Landscape

Automated external defibrillators (AEDs) are regulated as high-scrutiny medical devices in major markets, which influences product design, documentation, and lifecycle obligations. In the United States, AEDs fall under FDA device classification (21 CFR 870.5310) as Class III devices and are tied to Premarket Approval (PMA) expectations alongside ongoing postmarket oversight (including FDA Total Product Life Cycle reporting for the relevant product code). A key compliance inflection is the FDA Quality Management System Regulation (QMSR), which became effective on February 2, 2026, requiring manufacturers and critical suppliers to align quality systems to the updated framework and audit expectations.

In Europe, AED market access is governed by the Medical Device Regulation (EU) 2017/745 (EU MDR), with conformity assessment performed via Notified Bodies and supported by technical documentation, EU Declarations of Conformity, and UDI requirements (including Basic UDI-DI). The MDR transition window for certain legacy devices extends into 2027-2028 under the MDR transitional provisions, creating near-term pressure to maintain certificates while completing MDR upgrades. In the United Kingdom, the post-Brexit framework continues to evolve, and strengthened post-market surveillance provisions enacted in 2024 increase reporting and vigilance expectations for manufacturers and importers placing AEDs on the UK market.

Value Chain Analysis

The AED value chain begins with specialized upstream inputs, including high-reliability electronics (processors, sensors, and energy-storage components such as capacitors), lithium-based batteries, and single-use consumables such as electrode pads that rely on conductive hydrogels and engineered backing films. Because AEDs are FDA Class III devices, manufacturing and supplier controls are closely tied to regulated quality systems (commonly aligned to ISO 13485), design controls, and traceability for safety-critical parts. Electrode pad production is also a distinct sub-chain, using cleanroom-oriented steps such as film handling, hydrogel application, lamination, die-cutting, and sealed packaging to preserve shelf-life and performance.

Midstream, OEMs integrate hardware, embedded software, and increasingly connectivity modules for self-test telemetry and fleet-management dashboards, expanding requirements beyond assembly into software validation, cybersecurity processes, and cloud integration. Downstream, routes to market bifurcate between institutional sales (hospitals, EMS, and enterprise workplace deployments), public tenders linked to PAD programs, and distributor-led or e-commerce-led placements for schools, small businesses, and community sites. Service layers such as training, readiness monitoring, pad and battery replenishment, and compliance documentation are frequently bundled into subscription models, shifting some value capture from one-time device sales to recurring program management across installed fleets.

Market Opportunities and Future Outlook

Public-access mandates and program refresh cycles are creating whitespace in community and retail footprints where coverage remains uneven, while connectivity and compliance tooling are increasingly used as procurement differentiators. In the United States, state-level program updates provide a visible trigger for new placements and formalized compliance requirements: Maryland enacted Chapter 92 (Senate Bill 24) in April 2026 to revise its Public Access Automated External Defibrillator Program, including specific certification requirements for grocery stores and restaurants, with provisions taking effect October 1, 2026. These rules increase demand not only for devices, but also for documentation, inspection automation, and staff training packages that reduce the compliance burden for multi-site operators.

A second opportunity area is the shift from standalone devices to connected AED ecosystems that reduce inspection burden and improve readiness. FDA review activity around connected AEDs points in this direction, including the May 2026 status that HeartHero had an FDA premarket application under review for a connected AED paired with a mobile app for readiness monitoring and device status reporting. For incumbents, incremental PMA supplements support differentiation and refresh purchases within existing fleets, as shown by ZOLL Medicals PMA supplement approval (P160015/S025) in December 2025 for AED 3 labeling updates that incorporate post-approval study results. Together, these developments support demand for IoT-enabled fleet management, subscription-based AED-as-a-Service offerings, and replacement of older non-connected or legacy platforms in schools, workplaces, and public-access networks.